Sign in

CIK 0000034956

  • Non-accelerated filer
  • Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262593535
Phone
+1 919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Gift Director gave 567,871 shares (gift)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Exercise or conversion Chief Medical Officer acquired 3,581,000 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Exercise or conversion Director acquired 3,070,000 shares (option exercise)
  11. 4 Grant or award Director acquired 512,000 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award Chief Medical Officer acquired 666,098 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Director bought 32,000 shares at an average $1.42 ($45,547)
  19. 4 Open-market buy Director bought 86,000 shares at an average $1.43 ($123,240)
  20. 4 Open-market buy Director bought 32,000 shares at an average $1.47 ($47,000)

Page 4 of 11 · 206 filings